Clinical Trials Logo

Clinical Trial Summary

This was a dose-finding study to evaluate the efficacy, safety and tolerability of 3 different doses of LIK066 compared to placebo or empagliflozin in T2DM patients with heart failure


Clinical Trial Description

The study was prematurely discontinued on 04-May-2018 due to slow enrollment that would preclude obtaining study results in a timely manner. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03152552
Study type Interventional
Source Novartis
Contact
Status Terminated
Phase Phase 2
Start date July 25, 2017
Completion date June 6, 2018